-
1
-
-
79551705514
-
Výskyt a charakter infekcí vyvolaných Clostridium difficile u pacientů s průjmovým onemocněním v pražské fakultní nemocnici
-
Polívková S, Sýkorová B, Dž upová O, Reisingerová M, Beneš J. Výskyt a charakter infekcí vyvolaných Clostridium difficile u pacientů s průjmovým onemocněním v pražské fakultní nemocnici. Klin mikrobiol inf lék. 2010;16(6):206-210.
-
(2010)
Klin Mikrobiol Inf Lék
, vol.16
, Issue.6
, pp. 206-210
-
-
Polívková, S.1
Sýkorová, B.2
Dž upová, O.3
Reisingerová, M.4
Beneš, J.5
-
3
-
-
70649111291
-
Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007
-
Cheknis AK, Sambol SP, Davidson DM, et al. Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007. Anaerobe. 2009; 15: 230-233.
-
(2009)
Anaerobe
, vol.15
, pp. 230-233
-
-
Cheknis, A.K.1
Sambol, S.P.2
Davidson, D.M.3
-
4
-
-
79952640156
-
Geographical clustering of cases of infection with moxifloxacin-resistant Clostridium difficile PCR- ribotypes 012, 017 and 046 in Sweden, 2008 and 2009
-
pii =19 813
-
Akerlund T, Alefjord I, Dohnhammar U, et al. Geographical clustering of cases of infection with moxifloxacin-resistant Clostridium difficile PCR- ribotypes 012, 017 and 046 in Sweden, 2008 and 2009. Euro Surveill. 2011;16(10): pii =19 813.
-
(2011)
Euro Surveill
, vol.16
, Issue.10
-
-
Akerlund, T.1
Alefjord, I.2
Dohnhammar, U.3
-
5
-
-
78650825355
-
Clostridium difficile infection in Europe: A hospital-based survey
-
Bauer MP, Notermans DW, van Benthem BH, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011; 377: 63-73.
-
(2011)
Lancet
, vol.377
, pp. 63-73
-
-
Bauer, M.P.1
Notermans, D.W.2
Van Benthem, B.H.3
-
6
-
-
79955674549
-
Clostridium difficile PCR ribotype 176 in the Czech Republic and Poland
-
Nyč O, Pituch H, Matějková J, Obuch-Woszczatynski P, Kuijper EJ. Clostridium difficile PCR ribotype 176 in the Czech Republic and Poland. Lancet. 2011;377:1407.
-
(2011)
Lancet
, vol.377
, pp. 1407
-
-
Nyč, O.1
Pituch, H.2
Matějková, J.3
Obuch-Woszczatynski, P.4
Kuijper, E.J.5
-
7
-
-
34848889558
-
Clostridium difficile: Emergence of hypervirulence and fluoroquinolone resistance
-
DOI 10.1007/s15010-007-6113-0
-
Razavi B, Apisarnthanarak A, Mundy LM. Clostridium difficile: emergence of hypervirulence and fluoroquinolone resistance. Infection. 2007;35;5:300-307. (Pubitemid 47502344)
-
(2007)
Infection
, vol.35
, Issue.5
, pp. 300-307
-
-
Razavi, B.1
Apisarnthanarak, A.2
Mundy, L.M.3
-
8
-
-
77951026738
-
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
-
Cohen SH, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-455.
-
(2010)
Infect Control Hosp Epidemiol
, vol.31
, Issue.5
, pp. 431-455
-
-
Cohen, S.H.1
Gerding, D.N.2
Johnson, S.3
-
9
-
-
33947326884
-
Clostridium difficile-associated disease. Changing epidemiology and implications for management
-
Owens RC. Clostridium difficile-associated disease. Changing epidemiology and implications for management. Drugs. 2007;67(4):487-503.
-
(2007)
Drugs
, vol.67
, Issue.4
, pp. 487-503
-
-
Owens, R.C.1
-
10
-
-
33846156548
-
A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec
-
DOI 10.1086/510391
-
Hubert B, Loo VG, Bourgault AM, et al. A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec. CID. 2007;44:238-244. (Pubitemid 46079988)
-
(2007)
Clinical Infectious Diseases
, vol.44
, Issue.2
, pp. 238-244
-
-
Hubert, B.1
Loo, V.G.2
Bourgault, A.-M.3
Poirier, L.4
Dascal, A.5
Fortin, E.6
Dionne, M.7
Lorange, M.8
-
11
-
-
33846988271
-
Kolitida vyvolaná Clostridium difficile. Zpráva z kongresu ICAAC 2006
-
Beneš J, Sýkorová B. Kolitida vyvolaná Clostridium difficile. Zpráva z kongresu ICAAC 2006. Klin mikrobiol inf lék. 2006;12;6:247-251.
-
(2006)
Klin Mikrobiol Inf Lék
, vol.12
, Issue.6
, pp. 247-251
-
-
Beneš, J.1
Sýkorová, B.2
-
12
-
-
77952155563
-
Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection
-
Howell MD, Novack V, Grugurich P, et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010;170(9):784-790.
-
(2010)
Arch Intern Med
, vol.170
, Issue.9
, pp. 784-790
-
-
Howell, M.D.1
Novack, V.2
Grugurich, P.3
-
14
-
-
55249120179
-
New advances in Clostridium difficile infection: Changing epidemiology, diagnosis, treatment and control
-
DuPont HL, Garey K, Caeiro JP, Jiang ZD. New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control. Curr Opin Infect Dis. 2008;21:500-507.
-
(2008)
Curr Opin Infect Dis
, vol.21
, pp. 500-507
-
-
DuPont, H.L.1
Garey, K.2
Caeiro, J.P.3
Jiang, Z.D.4
-
15
-
-
40449114824
-
Clostridium difficile-associated disease in a setting of endemicity: Identification of novel risk factors
-
DOI 10.1086/523582
-
Dubberke ER, Reske KA, Yan Y, et al. Clostridium difficile - associated disease in a setting of endemicity: Identification of novel risk factors. CID. 2007;45:1543-1549. (Pubitemid 351411837)
-
(2007)
Clinical Infectious Diseases
, vol.45
, Issue.12
, pp. 1543-1549
-
-
Dubberke, E.R.1
Reske, K.A.2
Yan, Y.3
Olsen, M.A.4
McDonald, L.C.5
Fraser, V.J.6
-
16
-
-
70649107673
-
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Treatment guidance document for Clostridium difficile infection (CDI)
-
Bauer MP, Kuijper EJ, Dissel JT. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect. 2009;15:1067-1079.
-
(2009)
Clin Microbiol Infect
, vol.15
, pp. 1067-1079
-
-
Bauer, M.P.1
Kuijper, E.J.2
Dissel, J.T.3
-
17
-
-
36549073638
-
Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027
-
DOI 10.1111/j.1572-0241.2007.01539.x
-
Pépin J, Valiquette L, Gagnon S, Routhier S, Brazeau I. Outcomes of Clostridium dificile - associated disease treated with metroniazole or vancomycin before and after the emergence of NAPI/027. AM J Gastroenterol. 2007;102:2781-2788. (Pubitemid 350179349)
-
(2007)
American Journal of Gastroenterology
, vol.102
, Issue.12
, pp. 2781-2788
-
-
Pepin, J.1
Valiquette, L.2
Gagnon, S.3
Routhier, S.4
Brazeau, I.5
-
18
-
-
36048950259
-
Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system
-
DOI 10.1016/j.jinf.2007.09.015, PII S0163445307007840
-
Belmares J, Gerding DN, Prada JP, et al. Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. Journal of Infection. 2007;55:495-501. (Pubitemid 350082477)
-
(2007)
Journal of Infection
, vol.55
, Issue.6
, pp. 495-501
-
-
Belmares, J.1
Gerding, D.N.2
Parada, J.P.3
Miskevics, S.4
Weaver, F.5
Johnson, S.6
-
20
-
-
34547133720
-
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity
-
DOI 10.1086/519265
-
Zar FA, Bakkanagari SR, Moorthi KMLST, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. CID. 2007;45:302-307. (Pubitemid 47101025)
-
(2007)
Clinical Infectious Diseases
, vol.45
, Issue.3
, pp. 302-307
-
-
Zar, F.A.1
Bakkanagari, S.R.2
Moorthi, K.M.L.S.T.3
Davis, M.B.4
-
21
-
-
36549016574
-
The changing face of Clostridium difficile: What treatment options remain?
-
DOI 10.1111/j.1572-0241.2007.01533.x
-
Shen EP, Surawicz CM. The Changing Face of Clostridium difficile: What treatment options remain? Am J Gastroenterol. 2007;102:2789-2792. (Pubitemid 350179346)
-
(2007)
American Journal of Gastroenterology
, vol.102
, Issue.12
, pp. 2789-2792
-
-
Shen, E.P.1
Christina, M.S.2
-
22
-
-
36048970827
-
Pseudomembranózní kolitida
-
Bergmann D, Koten J, Beneš Z, Kohout P, Chlumská A. Pseudomembranózní kolitida. Vnitř Lék. 2007;53(10):1100-1107.
-
(2007)
Vnitř Lék
, vol.53
, Issue.10
, pp. 1100-1107
-
-
Bergmann, D.1
Koten, J.2
Beneš, Z.3
Kohout, P.4
Chlumská, A.5
-
23
-
-
77950861655
-
Success of self-administered home fecal transplantation for chronic Clostridium difficile infection
-
Silverman MS, Davis I, Pillai DR. Success of self-administered home fecal transplantation for chronic Clostridium difficile infection. Clinical Gastroenterology and Hematology. 2010;8: 471-473.
-
(2010)
Clinical Gastroenterology and Hematology
, vol.8
, pp. 471-473
-
-
Silverman, M.S.1
Davis, I.2
Pillai, D.R.3
-
24
-
-
77950936854
-
Clinical predictors and risk factors for relapsing Clostridium difficile infection
-
Cadena J, Thompson GR, Patterson JE, et al. Clinical predictors and risk factors for relapsing Clostridium difficile infection. Am J Med Sci. 2010; 339(4): 350-355.
-
(2010)
Am J Med Sci
, vol.339
, Issue.4
, pp. 350-355
-
-
Cadena, J.1
Thompson, G.R.2
Patterson, J.E.3
-
25
-
-
33847766665
-
Clostridium difficile in the intensive care unit: Epidemiology, costs, and colonization pressure
-
DOI 10.1086/511793
-
Lawrence SJ, Puzniak LA, Shadel BN, et al. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonisation pressure. Infect Control Hosp Epidemiol. 2007;28:123-130. (Pubitemid 46374151)
-
(2007)
Infection Control and Hospital Epidemiology
, vol.28
, Issue.2
, pp. 123-130
-
-
Lawrence, S.J.1
Puzniak, L.A.2
Shadel, B.N.3
Gillespie, K.N.4
Kollef, M.H.5
Mundy, L.M.6
|